- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/44 - Oxidoreductases (1)
Patent holdings for IPC class A61K 38/44
Total number of patents in this class: 1343
10-year publication summary
|
96
|
93
|
92
|
103
|
101
|
98
|
123
|
95
|
127
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Horizon Therapeutics USA, Inc. | 57 |
26 |
| The Regents of the University of California | 20355 |
15 |
| Exoxemis, Inc. | 26 |
15 |
| Modernatx, Inc. | 1280 |
14 |
| Translate bio, Inc. | 414 |
14 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3355 |
13 |
| President and Fellows of Harvard College | 6049 |
12 |
| Children's Medical Center Corporation | 1913 |
12 |
| CXL Ophthalmics, LLC | 19 |
12 |
| Synlogic Operating Company, Inc. | 112 |
11 |
| Lpoxy Therapeutics, Inc | 27 |
11 |
| The Trustees of the University of Pennsylvania | 4382 |
10 |
| Matoke Holdings Limited | 33 |
10 |
| Regeneron Pharmaceuticals, Inc. | 4505 |
10 |
| Yale University | 2461 |
10 |
| Genofocus, Inc. | 13 |
10 |
| The Cleveland Clinic Foundation | 1581 |
9 |
| Megmilk Snow Brand Co., Ltd. | 205 |
9 |
| North Carolina State University | 1581 |
9 |
| University of Washington | 2393 |
9 |
| Other owners | 1102 |